• Kevin Helash commences role as Chief Executive Officer of Biotalys

    Thursday October 5th 2023

  • Exploring 40 years of biotech excellence

    Wednesday October 4th 2023

  • Precirix appoints leading radiopharmaceutical and oncology experts to newly formed Scientific Advisory Board

    Wednesday October 4th 2023

  • Biotalys announces the appointment of Kevin Helash as Chief Executive Officer and Director to lead the company in its next growth phase

    Monday October 2nd 2023

  • SwiftPharma and Medace sign strategic collaboration agreement for biomanufacturing and purification of promising medicinal proteins.

    Wednesday September 27th 2023

  • Galapagos appoints Simon Sturge to its Board of Directors

    Tuesday September 19th 2023

  • The QbD Group launches its new Business & Communications division

    Monday September 18th 2023

  • Augustine Therapeutics expands its leadership team and R&D platform, enters regulatory development

    Tuesday September 12th 2023

  • Your news here?

  • SwiftPharma and the Population Council Pursue Agreement to Manufacture Griffithsin Needed for the Development of a Fast-Dissolving Insert for Protection Against HIV

    Friday September 8th 2023

  • SwiftPharma and AntoXa Corporation sign exclusive collaboration agreement to support the development and commercialization of a plant-made antibody against ricin exposure

    Friday September 1st 2023

  • FOx BIOSYSTEMS appoints Dr. Mark Truesdale as CEO

    Friday September 1st 2023


Strategic Partners